Allarity Therapeutics, Inc. Income Taxes Receivable
Allarity Therapeutics, Inc. (ALLR) had Income Taxes Receivable of $1.55 million as of 2023-06-30, per its 10-Q filed 2023-08-14.
Discontinued › Balance Sheet › Assets
us-gaap:IncomeTaxReceivable · last filed 2023-08-14
- 2023-06-30: Income Taxes Receivable $1.55M.
- 2023-03-31: Income Taxes Receivable $1.29M.
- 2022-12-31: Income Taxes Receivable $789.00K.
- 2022-09-30: Income Taxes Receivable $1.44M.
| Period end | Income Taxes Receivable |
|---|---|
| 2023-06-30 | $1.55M 10-Q · filed 2023-08-14 |
| 2023-03-31 | $1.29M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $789.00K 10-Q · filed 2023-08-14 |
| 2022-09-30 | $1.44M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $1.33M 10-Q · filed 2022-10-07 |
| 2022-03-31 | $1.27M 10-Q · filed 2022-05-27 |
| 2021-12-31 | $838.00K 10-K · filed 2023-03-13 |
| 2021-09-30 | $1.49M 10-Q/A · filed 2022-05-17 |
| 2020-12-31 | $908.00K 10-Q/A · filed 2022-05-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B |